These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19246976)

  • 1. Polymorphisms of steroid 5-alpha-reductase type I (SRD5A1) gene are associated to peripheral arterial disease.
    Signorelli SS; Barresi V; Musso N; Anzaldi M; Croce E; Fiore V; Condorelli DF
    J Endocrinol Invest; 2008 Dec; 31(12):1092-7. PubMed ID: 19246976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.
    Ellis JA; Panagiotopoulos S; Akdeniz A; Jerums G; Harrap SB
    J Hum Genet; 2005; 50(10):534-537. PubMed ID: 16155734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
    Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice.
    Windahl SH; Andersson N; Börjesson AE; Swanson C; Svensson J; Movérare-Skrtic S; Sjögren K; Shao R; Lagerquist MK; Ohlsson C
    PLoS One; 2011; 6(6):e21402. PubMed ID: 21731732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation.
    Schiffer L; Arlt W; Storbeck KH
    J Steroid Biochem Mol Biol; 2024 Jul; 241():106516. PubMed ID: 38582131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of SRD5A1 gene variants and testosterone with dysglycemia: Henan Rural Cohort study.
    Liu X; Wei D; Jiang J; Liu X; Tu R; Luo Z; Wang Y; Dong X; Qiao D; Shen F; Li R; Wang Y; Jin Y; Yu S; Huo W; Li L; Li W; Jing T; Wang C; Mao Z
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):599-607. PubMed ID: 31870594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
    Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
    Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
    Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid 5alpha-reductase 1 polymorphisms and testosterone/dihydrotestosterone ratio in male patients with hypospadias.
    Tria A; Hiort O; Sinnecker GH
    Horm Res; 2004; 61(4):180-3. PubMed ID: 14739525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Urol Oncol; 2015 Jul; 33(7):331.e1-7. PubMed ID: 25960412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
    Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
    Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
    Allen NE; Forrest MS; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues.
    Fouad Mansour M; Pelletier M; Tchernof A
    J Steroid Biochem Mol Biol; 2016 Jul; 161():45-53. PubMed ID: 26855069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A-ring reduction of 11-ketotestosterone is efficiently catalysed by AKR1D1 and SRD5A2 but not SRD5A1.
    Barnard L; Nikolaou N; Louw C; Schiffer L; Gibson H; Gilligan LC; Gangitano E; Snoep J; Arlt W; Tomlinson JW; Storbeck KH
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105724. PubMed ID: 32629108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.
    Shiota M; Fujimoto N; Yokomizo A; Takeuchi A; Itsumi M; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    Eur J Cancer; 2015 Sep; 51(14):1962-9. PubMed ID: 26169017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
    Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.